AACR 2017: gene editing & immunotherapy using LentiFlash
LentiFlash™: RNA delivery into primary T cells for both gene editing and immunotherapy applications
Two posters in the field of gene editing and immunotherapy have been shown by our experts at AACR 2017:
Gene editing: “Efficient KO of PD1 into primary T cells using a new non-integrative lentiviral particle expressing CRISPR/Cas9 system”
Immunotherapy: “Non-integrative lentiviral particles for immunotherapy: RNA delivery to drive tumoral antigen presentation in a safe and efficient way”
